Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses

Loading...
Thumbnail Image
Issue Date
2016-04-12
Authors
Chang, Kyeong-Ok
Kim, Yunjeong
Groutas, William C.
Advisor
Citation

Kyeong-Ok Chang, Yunjeong Kim, and William C. Groutas, inventors. Kansas State University Research Foundation and Wichita State University, assignees. Macrocyclic and peptidomimetic compounds as broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, caliciviruses and coronaviruses. United States patent: US 9,309,284. 2016, Apr 12.

Abstract

Antiviral protease inhibitors, including macrocylic transition state inhibitors and peptidomimetics are disclosed, along with related antiviral compounds, and methods of using the same to treat or prevent viral infection and disease. The compounds possess broad-spectrum activity against viruses that belong to the picornavirus-like supercluster, which include important human and animal pathogens including noroviruses, sapoviruses, enteroviruses, poliovirus, foot-and-mouth disease virus, hepatitis A virus, human rhinovirus (cause of common cold), human coronavirus (another cause of common cold), transmissible gastroenteritis virus, murine hepatitis virus, feline infectious peritonitis virus, and severe acute respiratory syndrome coronavirus.

Table of Content
Description
WSU inventor: William C. Groutas, Dept. of Chemistry, College of Liberal Arts and Sciences
Appl. No.: 14/398,290 filed May 2, 2013
publication.page.dc.relation.uri